Innovative Therapies for Today's Highest Performing Professional
Innovative Therapies for Today's Highest Performing Professional
Semaglutide is a “game-changer,” said Dr. Robert Kushner, obesity researcher at Northwestern University School of Medicine.
“This is the start of a new era of effective treatments for weight loss.”
Semaglutide is approved by the FDA for weight loss (along with diet and exercise) in overweight and obese adults with risk factors such as high blood pressure, high cholesterol, or diabetes. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is an analogue of a protein our body naturally produces to help prevent sugar spikes after meals by improving insulin production.
WellnessRx Centers is now able to offer a safe, affordable, compounded version of Semaglutide to prescribe to your patients. This low-dose, once a week, subcutaneous injection is equivalent to the pharmaceutical brand products,
but at a 50% -75% discount!
Tirzepatide was approved in the U.S. to treat diabetes and obesity.
It is now joining a frenzy of demand for diabetes and weight-loss medications. The cost of these GLP-1 medications can cost $1000 - $1600 a month with the pharmaceutical brand.
Tirzepatide stimulates two hormones (GIP and GLP-1) after eating to regulate appetite and the feeling of fullness (satiety), which is then communicated between the gut and the brain.
Tirzepatide's claim to fame was that it might be slightly more effective, with fewer GI side-effects. New research has shown
"Tirzepatide is more effective in blood sugar control and body weight loss than semaglutide, shows meta-analysis of 22 studies"
Wellness Rx Centers has contracted with an FDA-inspected, nationally-known compounding pharmacy to offer Tirzepatide to our WRx partners .
Contact us today to enroll with Wellness Rx Centers to start securing these GLPs at greatly reduced prices for your patients.
